Orange Book product · Brand (NDA)
TIVORBEX
INDOMETHACIN
At a glance
Feb 24, 2014
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 24, 2014
12 yr 6 mo ago
Today
Patent 8734847 expires
Listed drug product patent expiration.
Apr 23, 2030
in 3 yr 11 mo
Patent 8992982 expires
Listed drug product patent expiration.
Apr 23, 2030
in 3 yr 11 mo
Patent 9089471 expires
Listed method-of-use patent (U-55) expiration.
Apr 23, 2030
in 3 yr 11 mo
Pharmaceutical detail
Active ingredient
INDOMETHACIN
Strength
40MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 204768
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1984INDOMETHACINBrand (NDA)
NDA 018806 · PARKE DAVIS
- 1984INDOMETHACINBrand (NDA)
NDA 018829 · CHARTWELL MOLECULES
- 1984INDOMETHACINBrand (NDA)
NDA 018851 · HERITAGE
- 1984INDOMETHACINBrand (NDA)
NDA 018730 · IVAX SUB TEVA PHARMS
- 1984INDOMETHACINBrand (NDA)
NDA 018858 · RISING
- 1982INDOCIN SRBrand (NDA)
NDA 018185 · ZYLA
- —INDOCINBrand (NDA)
NDA 016059 · ZYLA LIFE SCIENCES
- 2017INDOMETHACINGeneric (ANDA)
ANDA 202711 · ZYDUS PHARMS
- 2017INDOMETHACINGeneric (ANDA)
ANDA 205215 · JUBILANT GENERICS
- 2017INDOMETHACINGeneric (ANDA)
ANDA 203501 · GLENMARK PHARMS LTD
- 2017INDOMETHACINGeneric (ANDA)
ANDA 204853 · NOVAST LABS
- 2016INDOMETHACINGeneric (ANDA)
ANDA 204243 · AUROBINDO PHARMA
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8734847 | Apr 23, 2030 | in 3 yr 11 mo | Product |
| 8992982 | Apr 23, 2030 | in 3 yr 11 mo | Product |
| 9089471 | Apr 23, 2030 | in 3 yr 11 mo | U-55 |

